OA09430A - "Nouveaux dérivés de l'amino chromanol, leur procédé de préparation et les compositions pharmaceutiques les renfermant". - Google Patents
"Nouveaux dérivés de l'amino chromanol, leur procédé de préparation et les compositions pharmaceutiques les renfermant".Info
- Publication number
- OA09430A OA09430A OA59664A OA59664A OA09430A OA 09430 A OA09430 A OA 09430A OA 59664 A OA59664 A OA 59664A OA 59664 A OA59664 A OA 59664A OA 09430 A OA09430 A OA 09430A
- Authority
- OA
- OAPI
- Prior art keywords
- image
- pharmaceutical compositions
- preparation process
- compositions containing
- new derivatives
- Prior art date
Links
- XPKQHJJKXONCHR-UHFFFAOYSA-N 2-amino-3,4-dihydrochromen-2-ol Chemical class C1=CC=C2OC(N)(O)CCC2=C1 XPKQHJJKXONCHR-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 102000004257 Potassium Channel Human genes 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004472 dialkylaminosulfonyl group Chemical group 0.000 abstract 1
- 230000001079 digestive effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 108020001213 potassium channel Proteins 0.000 abstract 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical class O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 abstract 1
- 230000016160 smooth muscle contraction Effects 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8813637A FR2637896B1 (fr) | 1988-10-17 | 1988-10-17 | Nouveaux derives de l'amino chromanol, leur procede de preparation et les compositions pharmaceutiques les renfermant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA09430A true OA09430A (fr) | 1992-10-15 |
Family
ID=9371088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA59664A OA09430A (fr) | 1988-10-17 | 1989-10-17 | "Nouveaux dérivés de l'amino chromanol, leur procédé de préparation et les compositions pharmaceutiques les renfermant". |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4999372A (ja) |
| EP (1) | EP0365416B1 (ja) |
| JP (1) | JPH068296B2 (ja) |
| AT (1) | ATE94543T1 (ja) |
| AU (1) | AU620157B2 (ja) |
| CA (1) | CA2000743A1 (ja) |
| DE (1) | DE68909167T2 (ja) |
| DK (1) | DK492089A (ja) |
| ES (1) | ES2059802T3 (ja) |
| FR (1) | FR2637896B1 (ja) |
| IE (1) | IE64369B1 (ja) |
| NZ (1) | NZ231029A (ja) |
| OA (1) | OA09430A (ja) |
| PT (1) | PT92007B (ja) |
| ZA (1) | ZA897821B (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1216461B (it) * | 1988-02-26 | 1990-03-08 | Milano | Derivati del 1_aril solfonil2_pirrolidinone loro procedimentodi preparazione e loro impieto come medicinali. |
| IT1244881B (it) * | 1990-12-13 | 1994-09-12 | Roussel Pharma Spa | Derivati dell'1-arilsolfonil 2-pirrolidone, loro procedimento di preparazione e i nuovi intermedi cosi' ottenuti ,il loro impiego come farmaci e le composizioni farmaceutiche che li contengono |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1495526A (en) * | 1974-05-31 | 1977-12-21 | Beecham Group Ltd | Chroman derivatives |
| ATE56007T1 (de) * | 1984-06-22 | 1990-09-15 | Beecham Group Plc | Wirksame benzopyranverbindungen. |
| GB8625185D0 (en) * | 1986-10-21 | 1986-11-26 | Beecham Group Plc | Active compounds |
| EP0277611B1 (de) * | 1987-02-04 | 1993-06-16 | Hoechst Aktiengesellschaft | Alkylsubstituierte N-Benzopyranyllactame, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen |
-
1988
- 1988-10-17 FR FR8813637A patent/FR2637896B1/fr not_active Expired - Lifetime
-
1989
- 1989-10-05 DK DK492089A patent/DK492089A/da not_active Application Discontinuation
- 1989-10-11 US US07/419,824 patent/US4999372A/en not_active Expired - Fee Related
- 1989-10-16 PT PT92007A patent/PT92007B/pt not_active IP Right Cessation
- 1989-10-16 NZ NZ231029A patent/NZ231029A/xx unknown
- 1989-10-16 AU AU42872/89A patent/AU620157B2/en not_active Ceased
- 1989-10-16 CA CA002000743A patent/CA2000743A1/fr not_active Abandoned
- 1989-10-16 ZA ZA897821A patent/ZA897821B/xx unknown
- 1989-10-16 IE IE331889A patent/IE64369B1/en not_active IP Right Cessation
- 1989-10-17 AT AT89402857T patent/ATE94543T1/de not_active IP Right Cessation
- 1989-10-17 EP EP89402857A patent/EP0365416B1/fr not_active Expired - Lifetime
- 1989-10-17 OA OA59664A patent/OA09430A/xx unknown
- 1989-10-17 ES ES89402857T patent/ES2059802T3/es not_active Expired - Lifetime
- 1989-10-17 DE DE89402857T patent/DE68909167T2/de not_active Expired - Fee Related
- 1989-10-17 JP JP1270154A patent/JPH068296B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2059802T3 (es) | 1994-11-16 |
| EP0365416B1 (fr) | 1993-09-15 |
| DE68909167D1 (de) | 1993-10-21 |
| FR2637896B1 (fr) | 1990-11-30 |
| EP0365416A1 (fr) | 1990-04-25 |
| IE893318L (en) | 1990-04-17 |
| ATE94543T1 (de) | 1993-10-15 |
| JPH02149578A (ja) | 1990-06-08 |
| ZA897821B (en) | 1990-07-25 |
| DE68909167T2 (de) | 1994-04-14 |
| AU620157B2 (en) | 1992-02-13 |
| PT92007A (pt) | 1990-04-30 |
| FR2637896A1 (fr) | 1990-04-20 |
| JPH068296B2 (ja) | 1994-02-02 |
| AU4287289A (en) | 1990-04-26 |
| CA2000743A1 (fr) | 1990-04-17 |
| DK492089D0 (da) | 1989-10-05 |
| NZ231029A (en) | 1990-10-26 |
| DK492089A (da) | 1990-04-18 |
| US4999372A (en) | 1991-03-12 |
| PT92007B (pt) | 1995-06-30 |
| IE64369B1 (en) | 1995-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS49918B (sr) | Upotreba glp-1, ili analoga za lečenje infarkta miokarda | |
| IL81349A (en) | Vinylphenol derivatives,their preparation and pharmaceutical compositions containing them | |
| HUT38256A (en) | Process for producing combined pharmaceutical compositions containing xantine derivatives and o-acetyl-salicylic acid or pharmaceutically acceptables salts | |
| GEP20032958B (en) | Adenosine Derivatives | |
| NO157377C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazodiazepiner. | |
| DE69200045D1 (de) | Thiazolopyrimidinderivate als Angiotensin-II-Rezeptorantagonisten: Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. | |
| DE3856258D1 (de) | Verfahren zur Herstellung eines Retardpräparates, das Diltiazem in einer einzigen Tagesdosis enthält | |
| KR830002510A (ko) | 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물 | |
| PT73280A (de) | Neue imidazol-derivate verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praparate | |
| OA09430A (fr) | "Nouveaux dérivés de l'amino chromanol, leur procédé de préparation et les compositions pharmaceutiques les renfermant". | |
| KR890012942A (ko) | 5-치환된 오르니틴 유도체 | |
| PT79969B (de) | Isoxazol-derivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| KR910004609A (ko) | 아미노케톤 유도체 및 그의 용도 | |
| KR900018100A (ko) | N-(5,6,7,8-테트라히드로피리도(2,3,-d)피리미딘-6-일-알카노일)-글루탐산 유도체 및 그의 제조방법 | |
| AU527523B2 (en) | Hexahydro-1,4-oxazepines | |
| OA09451A (fr) | "Nouveaux dérivés de la pyrrolidone, leur procédé de préparation et les compositions pharmaceutiques les renfermant". | |
| OA08237A (fr) | Nouveaux dérivés du triazole leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
| KR880002521A (ko) | 약제 제형 | |
| KR930004647B1 (ko) | 신장 질환 치료제 | |
| KR910018026A (ko) | α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제 | |
| KR910018347A (ko) | 술포닐알칸산 아미드 유도체 |